uniQure (QURE) Cash & Equivalents (2015 - 2026)
uniQure's (QURE) quarterly Cash & Equivalents came in at $140.0 million in Q1 2026, down 35.55% year-on-year from $217.2 million in Q1 2025, and up 74.47% quarter-over-quarter from $80.2 million in Q4 2025.
uniQure (QURE) Cash & Equivalents (2015 - 2026) Analysis & Trends
uniQure's Cash & Equivalents history runs 12 years deep, the most recent figure standing at $140.0 million for Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 35.55% year-over-year to $140.0 million in Q1 2026; TTM through Mar 2026 was $140.0 million, a 35.55% decrease from a year earlier, with the FY2025 full-year figure at $80.2 million, down 49.51% from the prior year.
- Cash & Equivalents grew to $140.0 million in Q1 2026 per QURE's latest filing, from $80.2 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $597.1 million in Q3 2025 and bottomed at $80.2 million in Q4 2025.
- The 5-year median for Cash & Equivalents is $243.1 million (2024), against an average of $297.8 million.
- Across the five-year window, Cash & Equivalents tumbled 70.69% in 2023 and jumped 137.28% in 2025, its largest moves.
- Year by year, Cash & Equivalents stood at $228.0 million in 2022, then grew by 5.85% to $241.4 million in 2023, then tumbled by 34.15% to $158.9 million in 2024, then tumbled by 49.51% to $80.2 million in 2025, then soared by 74.47% to $140.0 million in 2026.
- Per Business Quant, the three latest QURE Cash & Equivalents figures stand at $140.0 million (Q1 2026), $80.2 million (Q4 2025), and $597.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 2.83 Mn |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | 440.94 Mn |
| 10 | uniQure | 2.50 Bn | 2.50 Bn | 3.34 Mn | 139.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.99 Mn |
| Dec 31, 2025 | 80.24 Mn |
| Sep 30, 2025 | 597.06 Mn |
| Jun 30, 2025 | 253.78 Mn |
| Mar 31, 2025 | 217.23 Mn |
| Dec 31, 2024 | 158.93 Mn |
| Sep 30, 2024 | 251.63 Mn |
| Jun 30, 2024 | 287.88 Mn |
| Mar 31, 2024 | 243.06 Mn |
| Dec 31, 2023 | 241.36 Mn |
| Sep 30, 2023 | 229.48 Mn |
| Jun 30, 2023 | 513.60 Mn |
| Mar 31, 2023 | 153.85 Mn |
| Dec 31, 2022 | 228.01 Mn |
| Sep 30, 2022 | 440.31 Mn |
| Jun 30, 2022 | 500.52 Mn |
| Mar 31, 2022 | 524.89 Mn |
| Dec 31, 2021 | 556.26 Mn |
| Sep 30, 2021 | 578.46 Mn |
| Jun 30, 2021 | 677.33 Mn |